Gilead Sciences (GILD) Current Taxes (2009 - 2015)
Gilead Sciences (GILD) posted Current Taxes of $356.0 million for Q2 2015, up 263.27% quarter-over-quarter from $98.0 million in Q1 2015, and up 265.87% year-on-year from $97.3 million in Q2 2014.
Gilead Sciences (GILD) Current Taxes (2009 - 2015) Analysis & Trends
Gilead Sciences (GILD) has reported Current Taxes for 7 consecutive years, with $356.0 million the latest figure, recorded in Q2 2015.
- Current Taxes for Q2 2015 came in at $356.0 million, up 265.87% year-over-year; the trailing twelve-month figure through Jun 2015 was $356.0 million (up 265.87% YoY), and the FY2014 annual result was $105.0 million, up 854.55% from the prior year.
- Current Taxes was $356.0 million for Q2 2015 at Gilead Sciences, up from $98.0 million in the prior quarter.
- Over five years, Current Taxes peaked at $356.0 million in Q2 2015 and troughed at $2.5 million in Q1 2011.
- Average Current Taxes over 5 years is $59.5 million, with a median of $26.5 million recorded in 2011.
- The widest YoY moves for Current Taxes: up 2079.54% in 2011, down 93.62% in 2011.
- Over 5 years, Current Taxes stood at $40.6 million in 2011, then slumped by 66.97% to $13.4 million in 2012, then fell by 17.93% to $11.0 million in 2013, then soared by 854.55% to $105.0 million in 2014, then jumped by 239.05% to $356.0 million in 2015.
- Per Business Quant data, the three most recent Current Taxes figures were $356.0 million in Q2 2015, $98.0 million in Q1 2015, and $105.0 million in Q4 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 1.09 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -1.30 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 3.95 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 3.13 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | 93.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 356.00 Mn |
| Mar 31, 2015 | 98.00 Mn |
| Dec 31, 2014 | 105.00 Mn |
| Sep 30, 2014 | 43.78 Mn |
| Jun 30, 2014 | 97.30 Mn |
| Mar 31, 2014 | 152.95 Mn |
| Dec 31, 2013 | 11.00 Mn |
| Sep 30, 2013 | 10.65 Mn |
| Jun 30, 2013 | 37.97 Mn |
| Mar 31, 2013 | 19.24 Mn |
| Dec 31, 2012 | 13.40 Mn |
| Sep 30, 2012 | 17.09 Mn |
| Jun 30, 2012 | 11.85 Mn |
| Mar 31, 2012 | 14.49 Mn |
| Dec 31, 2011 | 40.58 Mn |
| Sep 30, 2011 | 33.67 Mn |
| Jun 30, 2011 | 5.44 Mn |
| Mar 31, 2011 | 2.46 Mn |
| Dec 31, 2010 | 1.86 Mn |
| Sep 30, 2010 | 38.71 Mn |